Loading clinical trials...
Loading clinical trials...
Low Dose Versus Weight-based Intravenous Acyclovir for Herpes Simplex Virus Prophylaxis in the Neutropenic Patient
Conditions
Interventions
acyclovir sodium
Locations
1
United States
Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
Start Date
November 1, 2008
Primary Completion Date
November 1, 2013
Completion Date
November 1, 2013
Last Updated
July 6, 2018
NCT04065971
NCT05429346
NCT03282916
NCT05226949
NCT03626376
NCT00000635
Lead Sponsor
Wake Forest University Health Sciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions